Aldose reductase-deficient mice develop nephrogenic diabetes insipidus
- PMID: 10913167
- PMCID: PMC86061
- DOI: 10.1128/MCB.20.16.5840-5846.2000
Aldose reductase-deficient mice develop nephrogenic diabetes insipidus
Abstract
Aldose reductase (ALR2) is thought to be involved in the pathogenesis of various diseases associated with diabetes mellitus, such as cataract, retinopathy, neuropathy, and nephropathy. However, its physiological functions are not well understood. We developed mice deficient in this enzyme and found that they had no apparent developmental or reproductive abnormality except that they drank and urinated significantly more than their wild-type littermates. These ALR2-deficient mice exhibited a partially defective urine-concentrating ability, having a phenotype resembling that of nephrogenic diabetes insipidus.
Figures
References
-
- Bichet D G, Oksche A, Rosenthal W. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol. 1997;8:1951–1958. - PubMed
-
- Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. - PubMed
-
- Brown D, Shields G I, Valtin H, Morris J F, Orci L. Lack of intramembranous particle clusters in collecting ducts of mice with nephrogenic diabetes insipidus. Am J Physiol. 1985;249:F582–F589. - PubMed
-
- Costantino L, Rastelli G, Vianello P, Cignarella G, Barlocco D. Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches. Med Res Rev. 1999;19:3–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials